. Author manuscript; available in PMC: 2017 Nov 1.

Published in final edited form as: Clin Appl Thromb Hemost. 2016 Dec 21;23(8):1052–1059. doi: 10.1177/1076029616683804

Table 3.

Comparison of PLT Count and MPV Between Thrombotic and Non-Thrombotic MI Groups.

Biomarkers	Time Point	Thrombotic MI (n = 22)		Non-Thrombotic MI (n = 12)		P value
Biomarkers	Time Point	Mean ± SD	95% CI	Mean ± SD	95% CI	P value
Platelet count	Acute phase	223.5 ± 84.4	186.0–260.9	211.6 ± 56.3	175.8–247.4	0.81^a
Platelet count	Quiescent phase	223.5 ± 75.3	184.7–262.2	225.3 ± 63.6	172.1–278.4	1.00^a
Mean platelet volume	Acute phase	8.89 ± 1.15	8.38–9.40	9.00 ± 0.72	8.54–9.45	0.43^a
Mean platelet volume	Quiescent phase	8.79 ± 1.32	7.77–9.71	8.99 ± 0.80	8.32–9.66	0.41^a

Abbreviations: CI, confidence interval; MI, myocardial infarction; MPV, mean platelet volume; PLT, platelet; SD, standard deviation.

Wilcoxon rank sum test P value.